Yes, insurance companies are denying coverage for cortisone injections with increasing frequency, often miscategorizing routine 15-minute dermatology procedures as surgical operations to justify the denial. When a dermatologist performs a cortisone injection for cystic acne or inflamed lesions—a procedure that typically takes 15 minutes in an office setting—some insurers bill and deny it using surgical procedure codes, claiming the treatment is “experimental” or “investigational,” even though cortisone injections have been a standard acne treatment for decades. A patient might receive a $350 monthly bill for what should be a covered dermatological procedure, then face a denial letter citing procedural classifications that don’t actually apply to their treatment.
The core problem isn’t that cortisone injections are expensive or unproven. The issue is a mismatch between how insurers classify these procedures and how they’re actually delivered. An office-based steroid injection for acne takes 15 minutes and costs between $150 and $300 per treatment without insurance, yet when billed under the wrong procedure codes or reviewed by an insurer unfamiliar with dermatology standards, coverage gets denied outright. This gap between reality and insurance classification has become more common, particularly following Medicare’s introduction of new prior authorization requirements in early 2026.
Table of Contents
- Why Are Insurance Companies Denying Cortisone Injections for Acne?
- The Real Cost and What Insurance Actually Should Cover
- How the WISeR Program and Prior Authorization Are Affecting Steroid Injection Coverage
- What to Do If Your Cortisone Injection Is Denied
- The Broader Pattern of Insurance Misclassification in Dermatology
- Cortisone Injection Alternatives When Insurance Won’t Cover
- The Future of Steroid Injection Coverage: What’s Changing
- Conclusion
Why Are Insurance Companies Denying Cortisone Injections for Acne?
The primary reason insurers deny cortisone injection coverage is procedural misclassification. When a dermatologist injects a steroid directly into an inflamed acne cyst or lesion, this should be coded as a therapeutic injection—a routine, in-office procedure. However, some insurers wrongly classify it under surgical procedure codes or claim it’s experimental and investigational, creating grounds for automatic denial. This doesn’t reflect medical reality: cortisone injections for cystic acne have been standard dermatological practice for decades and are recommended in most clinical guidelines. Medicare’s situation has worsened with the WISeR (Winning Strategies for Effective Review) Program launched in January 2026, which applies new prior authorization requirements to epidural steroid injections and related procedures. While the WISeR program specifically targets spinal injections, some insurers have begun applying similar restrictions to all steroid injection procedures, triggering initial denial rates between 30 and 40 percent.
Physicians have publicly criticized the program, citing “fundamental misunderstanding of anatomy and technical aspects” in the denial determinations. even though these authorizations are supposed to prevent unnecessary procedures, they’re being applied too broadly and catching routine acne treatments in the net. Another factor is cost shifting. Specialized formulations like Zilretta, a prolonged-release corticosteroid, cost approximately $784 for a three-month supply. insurance companies may deny coverage on one patient to protect themselves from paying for higher-cost alternatives, using “not medically necessary” language as cover for what’s actually a cost-containment strategy. The irony is that refusing to cover a $350 monthly injection often forces patients to pursue more expensive alternatives—oral medications with systemic side effects, or dermatology visits that could have been avoided with timely steroid injection treatment.
The Real Cost and What Insurance Actually Should Cover
Without insurance, a single cortisone injection for acne costs between $150 and $300, depending on the injection site, the volume of steroid required, and the dermatologist’s location. If a patient requires monthly injections—common for severe cystic acne—that’s $1,800 to $3,600 out of pocket annually for a procedure that takes 15 minutes. Medicare data reveals what these procedures actually cost the healthcare system: $19 in ambulatory surgical centers and $67 in hospital outpatient settings. This massive gap between what patients pay and what the procedure costs Medicare shows how broken the insurance pricing system is. The limitation here is that even when coverage is approved, copays and coinsurance can still be substantial.
An insurer might cover the procedure at 80 percent, leaving the patient with a $70 to $60 copay per injection. Over a year of monthly treatments, that’s $600 to $840 out of pocket—plus the cost of any additional acne medications, follow-up visits, or related treatments. Patients with high-deductible plans face the full $150–$300 cost until their deductible is met, effectively making the procedure inaccessible during the first months of the calendar year. Another warning: specialized steroid formulations covered by some insurance plans may not be available at your dermatologist’s office. Your insurer might approve Kenalog (a standard, lower-cost steroid) but not Triamcinolone acetonide or other formulations, limiting your treatment options even when coverage is granted. This means you could have insurance approval that’s technically useless because the covered product isn’t available where you receive care.
How the WISeR Program and Prior Authorization Are Affecting Steroid Injection Coverage
Medicare’s WISeR Program, which took effect in January 2026, has created a new bottleneck for steroid injection approval. The program mandates prior authorization for epidural steroid injections, among other common procedures, to reduce what Medicare considers unnecessary spending. However, physicians and patient advocates have raised alarms about initial denial rates of 30 to 40 percent—significantly higher than historical rates—with many physicians reporting that the authorization reviewers lack dermatological or anatomical expertise. For acne patients on Medicare (including those on disability or with early qualifying conditions), this means additional wait time before treatment. A dermatologist might prescribe a cortisone injection for a severe cyst, but can’t administer it until prior authorization is obtained—a process that can take one to two weeks.
During that waiting period, the cyst may become infected, the inflammation may worsen, or the patient may develop scarring. The procedure that was supposed to prevent these complications becomes delayed enough that it sometimes fails to prevent them. The concerning part is that private insurance companies are watching Medicare’s moves closely. Some private insurers have already begun implementing similar prior authorization requirements for steroid injections, even though they’re not technically mandated to follow WISeR. If your insurer sees Medicare tightening coverage, they’re likely to follow suit. This means that even if your plan covered cortisone injections without pre-approval six months ago, that policy may change soon.
What to Do If Your Cortisone Injection Is Denied
The first step after a denial is to gather your documentation and appeal. Medicare appeals are surprisingly successful: 82 percent of Medicare appeals for steroid injection denials are partially or fully successful when proper documentation is provided. This means your dermatologist’s medical records, including photos of your acne, notes about why injections are medically necessary (e.g., “to prevent scarring” or “due to failed response to oral antibiotics”), and any relevant clinical guidelines significantly improve your chances. For private insurance, appeal success rates are over 50 percent with proper documentation, though they’re lower than Medicare.
Your dermatologist should submit a detailed letter explaining why the cortisone injection is medically necessary in your specific case—not just “the patient has acne,” but “this patient has cystic lesions unresponsive to oral medications, at risk of permanent scarring, and steroid injection is the standard treatment.” Include reference to dermatology guidelines like those from the American Academy of Dermatology. The tradeoff is that appealing takes time: you’re looking at one to three weeks of waiting while your case is reviewed, during which your acne may worsen. A practical alternative, if prior authorization is the barrier, is to ask your dermatologist whether the injection can be performed as an office procedure paid out of pocket, with a subsequent insurance claim filed for reimbursement. Some insurers are faster at reimbursement than prior authorization. If the $300 out-of-pocket cost is prohibitive, your dermatologist may offer a payment plan or have samples of lower-cost steroid formulations available.
The Broader Pattern of Insurance Misclassification in Dermatology
Cortisone injection denials are part of a larger trend of insurance companies misclassifying routine dermatological procedures. Moles and lesions removed in-office are sometimes coded as “surgical” even though they take 10 minutes. Cryotherapy (freezing off precancerous spots) gets denied as “cosmetic.” Steroid injections for inflammatory conditions get flagged as “experimental.” The common thread is that insurers use vague, broad denial categories that don’t reflect clinical reality, betting that most patients won’t appeal. A warning: even after a successful appeal, don’t assume future denials won’t happen. Insurance decisions aren’t consistent across different reviewers, and a procedure that was approved last month might be denied next month under a different reviewer’s interpretation of the same policy.
Keep copies of all approvals and appeal documents. If you receive a second denial for the same procedure, cite the previous approval in your appeal—this creates a stronger case and highlights the insurer’s inconsistency. The limitation is that fighting individual denials is time-consuming and emotionally draining. You’re essentially arguing with a non-clinician reviewer about whether a dermatologist’s medical judgment is correct. Your dermatologist is the expert, yet their recommendation is being second-guessed by an insurance company employee who may have no medical training. This imbalance is built into the system, and individual appeals, while sometimes successful, don’t fix the structural problem.
Cortisone Injection Alternatives When Insurance Won’t Cover
If insurance denial becomes chronic, you have other options, though each has tradeoffs. Oral antibiotics (doxycycline, minocycline) are typically covered by insurance but carry risks of photosensitivity, yeast infections, and long-term antibiotic resistance. Isotretinoin (Accutane) is covered for severe acne but requires monthly blood tests, strict contraception if applicable, and carries risk of serious side effects.
Both are systemic treatments affecting your whole body, whereas a steroid injection affects only the specific lesion. Topical retinoids and benzoyl peroxide are affordable without insurance—typically $20 to $60 per month—but work slowly and don’t treat already-inflamed cystic lesions quickly. Many dermatologists will recommend using topicals as a preventive while pushing for insurance coverage of steroid injections for acute flares. This combination approach is often more effective than either treatment alone.
The Future of Steroid Injection Coverage: What’s Changing
As Medicare’s WISeR Program matures and more private insurers adopt prior authorization for steroid procedures, coverage is likely to become even more restrictive in the short term. However, there’s a counterargument gaining traction: physicians and patient groups are pushing back against overly broad prior authorization, and some state legislatures are passing laws requiring insurers to respond to authorization requests within specific timeframes (often 24 to 48 hours for urgent procedures).
The long-term outlook is uncertain but may favor patients. If prior authorization delays continue to cause harm and physicians continue to publicly challenge the program’s medical basis, we may see regulatory changes that exempt routine office procedures like dermatological steroid injections from prior authorization altogether. Until then, expect denials to continue—but also know that these denials are frequently reversible with the right appeal documentation and persistence.
Conclusion
Insurance denials for cortisone injections represent a systemic failure where cost-control mechanisms override clinical judgment. A procedure that costs Medicare $19 to $67 is being denied to patients paying $150 to $300 out of pocket, often using justifications that don’t reflect how the procedure is actually performed or why it’s medically necessary. The introduction of Medicare’s WISeR Program in early 2026 has worsened the problem, creating a bottleneck where even approved treatments face new delays and higher denial rates. Your next step should be this: if your cortisone injection is denied, appeal immediately with detailed medical documentation from your dermatologist.
Eighty-two percent of Medicare appeals succeed with proper documentation, and over half of private insurance appeals do as well. Don’t accept the denial at face value. Request your dermatologist’s full justification for why the injection is medically necessary, and cite it in your appeal. If you’re on Medicare or anticipating prior authorization delays, ask your dermatologist about alternatives like paying out of pocket and claiming reimbursement, or whether lower-cost steroid formulations are available. The system is broken, but within that broken system, persistence and documentation still work.
You Might Also Like
- Insurance Denied Coverage for Accutane Costing $600 Per Month…Liver Damage Risk Requires Monthly Blood Tests That Cost $150 Each
- Insurance Denied Coverage for Spironolactone Blood Work Costing $200 Per Month…Required Every 3 Months While on Treatment
- Insurance Denied Coverage for Laser Scar Treatment Costing $3,500 Per Month…Classified as Cosmetic Despite Causing Clinical Depression
